HomeAI · summaries
Storia in 4 fonti
AstraZeneca beats Q2 profit expectations, holds outlook
The company’s core earnings for the three months ended June 30 rose 18% to $2.63 per share, while total revenue jumped 5% to $15.38 billion at constant-currency rates.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
AstraZeneca beats Q2 profit expectations, holds outlook
The company’s core earnings for the three months ended June 30 rose 18% to $2.63 per share, while total revenue jumped 5% to $15.38 billion at constant-currency rates.
- ·
hurriyetdailynews.com
AstraZeneca quarterly net profit rises on strong cancer drug sales - Latest News
British pharmaceutical giant AstraZeneca yesterday said net profit rose in its second quarter, driven once again by strong growth in sales of its cancer drugs.
